Medtronic plc — Director's Dealing 2022

Aug 3, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2022-08-01

Reporting Person: Wall Brett A. (EVP & Pres Neuroscience)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-01	Ordinary Shares	A	7521	—	Acquired	25646	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-01	Performance Share Units	$	A	18802	Acquired		Performance Share Units (18802)	Direct
2022-08-01	Stock Option (Right to Buy)	$93.08	A	59433	Acquired	2032-08-01	Ordinary Shares (59433)	Direct

Footnotes

F1: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.

F2: Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

F3: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 18,802 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

F4: Vests on August 1, 2025.

F5: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.